Currently predicting for Thu, 4 Jun 2026

SAVA Prediction Chart

SAVA Predictions History

Latest community submissions for SAVA.
Predictor Target Session Target Price Result Direction Accuracy Score
Jul 10, 2025 Bullish $2.16 X 0
Feb 25, 2025 $2.57 +2.64% $2.42 X 93.97% 0
Feb 25, 2025 $2.54 +1.65% $2.42 X 94.99% 0
jesus acevedo sr jesus acevedo sr @jesusacevedosr.129162
Feb 25, 2025 $2.50 +0.00% $2.42 V 96.69% 1
Jan 27, 2025 $2.69 +6.71% $2.47 X 91.13% 0
Jan 27, 2025 $2.63 +4.20% $2.47 X 93.69% 0
Craig Craig @Craig.113473
Jan 27, 2025 Bullish $2.47 X 0
Jan 21, 2025 $2.54 -7.56% $2.62 V 97.03% 1
Jan 21, 2025 $2.88 +4.72% $2.62 X 90.08% 0
Craig Craig @Craig.113473
Jan 21, 2025 Bullish $2.62 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SAVA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CASSAVA SCIENCES INC.
Cassava Sciences
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sci...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE